Bengal Achieves Significant Success in Preventing Hepatitis B

Published On 2024-11-02 07:45 GMT   |   Update On 2024-11-02 07:45 GMT

Kolkata: West Bengal Chief Minister Mamata Banerjee announced on Tuesday that the state has achieved "remarkable success" in combating Hepatitis B, with a current prevalence rate of just 0.07%.

Banerjee also hailed the mass vaccination programme conducted in the state since 2022 to prevent Hepatitis B among pregnant mothers and newborns.

According to the PTI report, the CM said in a statement, “It is with great pleasure that I would like to inform you that our state West Bengal has achieved remarkable success in preventing Hepatitis B. A recent national survey showed a prevalence rate of 0.07 per cent in West Bengal, indicating the effectiveness of strong Hepatitis B prevention measures in the state.”

Also Read:WHO releases new guidelines on hepatitis B

“Our success rate is better than expected. In the coming days, this programme will be followed more strongly to eliminate its outbreak in the state,” Banerjee added.

She also referred to a survey conducted by the National Viral Hepatitis Control Programme to find out the infection statistics of Hepatitis B among children under 5 years, news agency PTI reported.  

Hepatitis B is a viral infection that affects the liver.

Medical Dialogues team had earlier reported that the Sanjay Gandhi Post Graduate Institute of Medical Sciences (SGPGIMS) will be providing free DNA testing for hepatitis B and RNA testing for hepatitis C, at the Department of Hepatology, it was announced. The cost of these tests would be borne by the Uttar Pradesh Government through the National Viral Hepatitis Control Programme (NVHCP). The patients willing to avail these services need to register themselves in the hepatology OPD.

Also Read:West Bengal passes anti-rape 'Aparajita' bill

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News